now been several studies addressing the association of HIV-1 burden, as measured by p24 antigen [4] , quantitative coculture [7] , or plasma RNA [8, 9] , with transmission. Some of these studies have suggested that there may be a "threshold" of virus necessary before transmission can occur [7] . Most of these studies have been performed with limited sample size on select populations, and none have looked at the interaction of virus burden and immune status. Other studies have demonstrated an inverse, though not absolute, relationship between decline in CD4 lymphocyte count and an increased virus load [10] [11] [12] .
The objective of this study was to determine the interrelated contributions of maternal immunologic status, as measured by lymphocyte subsets, and virologic status, as measured by coculture, to the risk of perinatal HIV -1 transmission.
Methods
The Women and Infants Transmission Study (WITS), which began recruiting subjects in December 1989, is a multisite epidemiologic study evaluating maternal factors related to perinatal HIV transmission among women in the United States. The subjects are pregnant HIV-infected women whose demographic profile reflects the HIV epidemic among women in the United States.
Subjects. Data from HIV-infected pregnant women and their offspring enrolled in WITS from late 1989 through August 1993 were included in the analyses. The women were recruited from sites in New York City; Boston/Worcester, Massachusetts; San Juan, Puerto Rico; and Chicago either during pregnancy or at delivery. Only data from the first WITS pregnancy that resulted in a singleton live birth were used for this analysis to avoid problems of lack of independence.
Flow cytometry. Immunophenotypic evaluation of patient samples was performed as previously described [13, 14] . All ofthe laboratories used the same lots of monoclonal antibodies (Becton Dickinson, San Jose, CA), the same instrumentation (FACScan; Becton Dickinson), and the same protocol to make these measurements. For the purposes of this study, the results from the CD3/ CD4-and CD3/CD8-labeled cells are referred to as CD4 and CD8 cells. All of the laboratory sites participated in the monthly flow cytometry quality control program of the Division of AIDS of the National Institute of Allergy and Infectious Diseases. Over the study period, all WITS laboratories were fully certified by this proficiency testing program. Sites began the full flow cytometry protocol over the first year of the study. For that reason there were more data on CD4 and CD8 cells than on the other markers.
Peripheral blood mononuclear cell (PBMC) cultures ofHIV-l. During the first part of the study, 203 women had 436 qualitative macrocultures performed. By October 1991, all laboratories had changed over to quantitative microcultures. In the later part of the study, therefore, another 392 quantitative microcultures were performed. Blood, in heparinized tubes, was obtained from the mothers for culture at study entry (which was at any time between first trimester through delivery) and at as many as three additional times, at weeks 25 and 34 and at delivery. Blood was collected from infants for culture as previously described [15] . All of the laboratory sites participated in the virology quality control program of the Division of AIDS of the National Institute of Allergy and Infectious Diseases [16] .
Qualitative macroculture was performed according to the AIDS Clinical Trials Group (ACTG) consensus protocol. Details of the assay procedure have been published elsewhere [17] . The quantitative PBMC microculture assay was performed using the ACTG consensus protocol [17] . In the case of some pediatric specimens with limited volume, the first well was assayed singly [15, 17] . The titer in infectious units per million cells (IUPM) was determined by a maximum likelihood method [18] , automatically calculated by an on-site software program (Dataworks RLMP, Seattle). Only those determinations with percentage of goodness of fit >.05 were used in the analysis of quantity of virus. This resulted in the exclusion of 7.6% of positive culture results. When quantitative microcultures were used for a qualitative value, they were considered positive if at least 2 wells in the first 4 wells of the dilution series contained > 30 pg/ml. HIV p24 antigen at either 14 or 21 days.
Definition of an infected infant. For purposes of analysis, before availability of serology data in the second year of life, interim working definitions of infant infection status were developed by WITS investigators. An infant was considered to be HIV-infected when 2 separate PBMC cultures were positive. An infant was considered not infected if at least 2 peripheral cultures were negative; both of these cultures were obtained at~1 month of age and at least 1 culture was obtained at~6 months of age. Moreover, to be considered by this working definition to be uninfected, there could be no positive cultures at any time [15] . Infants who did not meet these criteria for negative or positive culture status were considered indeterminate. Only infants who were ascertained to be HIV-positive or -negative were included in the present study.
Maternal drug use variable. Informed consent for maternal WITS enrollment included permission to obtain interviews for selfreport data as well as urine for drug toxicology to determine the drug use behaviors of each of the pregnant women. To ensure confidentiality, clinical sites were blinded to urine toxicology results, and assays from pregnancy were run only after the birth of the infant. Specimens were batched and sent to the Center for Human Toxicology reference laboratory in Salt Lake City. Urine was initially screened by immunoassay for cocaine, opiates, methadone, alcohol, and other drugs. In cases in which screens were positive and women had not reported drug use, the screens were confirmed by gas chromatography and mass spectrometry (GC/MS).
For these analyses, a woman was defined as a drug user during the pregnancy if she reported use of cocaine/crack or opiates (heroin, methadone) or intravenous drug use based on a structured interview at enrollment or at a subsequent pregnancy visit (or both) or if there was a positive urine drug screen at any visit during pregnancy or at delivery and confirmatory GC/MS. A woman was defined as a drug nonuser based on negative self-report and absence of a positive urine screen. Urine screens were obtained for 592 (85%) of 697 women overall and for 412 (87%) of 475 evaluable women, who are the subject of this report.
Statistical analyses. Analyses assessing the relationship of maternal virus load and lymphocyte subsets to infant infection included only the mother-infant pairs in which the infants were defined as infected or noninfected. The quantification of maternal lymphocyte phenotypes was expressed using percentages rather than absolute counts to minimize the impact of the variability of leukocyte counts during pregnancy and delivery as well as to avoid the introduction of another source of variability introduced by the lymphocyte count [19] . Mean percentages for each lymphocyte phenotype in the peripheral blood samples of each woman were generated from all available prenatal and delivery visit laboratory values. Quartile values were generated using SAS Proc Univariate (SAS Institute, Cary, NC).
Cumulative qualitative and quantitative culture results for samples obtained from women during pregnancies were analyzed. For the qualitative results, all available cultures obtained from a patient during pregnancy and delivery were assessed, and the patient was classified as always, sometimes, or never positive based on 1-4 cultures per woman. For the quantitative results, geometric mean quantitative IUPM calculations excluding values outside of .05 probability of goodness of fit (PGOF) [18] were used to characterize the women's virologic status.
The association between various maternal immunologic and virologic variables and the proportion of infants infected was determined by the Mantel extension test [20] . These analyses examined associations seen with rates of infant infection rather than transmission rates. They were not intended to estimate actual rates of transmission, since the infected infants might have been somewhat overrepresented in the analysis. This is because infants could have met the definition of "infected" by 1 or 2 months of age, while the status of "uninfected" infants could not be determined until they were 6 months of age.
Multivariate logistic regression was done using BMDP (BMDP Statistical Software, Los Angeles) [21] . In these analyses, the outcome variable was infant HIV infection (yes, no). Maternal covari-ates entered into regression models included the primary independent variables of interest: quartiles of maternal CD4 and CD8 cell percentages and maternal culture positivity (always vs. not always positive). On the basis of previous findings in the WITS cohort, several other maternal covariates were also entered into the regression models. These included maternal zidovudine use during pregnancy (yes, no), duration of membrane rupture «4 h, h, 24 h), maternal drug use during pregnancy (yes, no), birth weight <2500 g, and gestational age <37 weeks.
Results
As of 1 September 1993, there were 788 HIV-infected pregnancy enrollments of 697 women and 566 enrolled infants in WITS. The elimination of 19 twins (l0 pairs with 1 stillbirth) and 27 infants of repeat pregnancies resulted in 520 infants available for analysis. Among these 520 singleton infants, 94 infants were determined to be infected, 381 were uninfected, 39 were indeterminate, and there were no available data for 6. Thus, 475 mother-infant pairs were available for inclusion in these analyses.
Characteristics ofthe study population. Demographic, laboratory, and zidovudine data on the women as well as the infection status of the infants are presented in table 1. The 475 women in the subset analyzed for this report did not differ in terms of age, parity, drug use, or other demographics from the overall group of 697 pregnant enrollees. Median CD4 and CD8 cell counts and percentages and percentages of positive cultures were similar between the subgroup and the overall group.
Infant infection status and maternal immunologic findings. The relationship between maternal lymphocyte phenotypes in pregnancy and HIV infection status of the infant is presented in table 2. Women were divided into quartiles according to the mean percentage ofthe given lymphocyte phenotype. Low CD4 and high CD8 cell percentage correlated strongly with infant infection (P < .001, P = .001, respectively). These same patterns were seen in women not receiving antiretroviral therapy during pregnancy (data not shown; P < .001 and P = .005, respectively). Among the 106 women receiving zidovudine, the trend appeared similar but was not statistically significant (P = .14 and P = .17, respectively). Of the three CD8 cell subsets measured, CD8/CD38 and CD8IDR cells revealed a significant trend and CD8/57 cells showed a similar pattern (table 2) . For the following analysis, only CD8 cell values from subjects after October 1991 were used because this was when the activation panel was added to the protocol. When either CD8/CD38 or CD8IDR cell values were put into a multivariate model with CD8 cell values, with the outcome being maternalinfant transmission, CD8 cell values were excluded by backward elimination. In this maternal cohort, CD3, CD19, and CD 15/56 cell measurements were not significantly related to the infant's infectious outcome.
Infant infection status and maternal HIV-I culture results. Of the 928 HIV cultures obtained from women during preg- * Drug use was defined as crack/cocaine, opiates, or intravenous drug use.
t AIDS Clinical Trials Group (ACTG) 076 was a study ofHIV-1 transmission by infected asymptomatic zidovudine-naive women with CD4 lymphocytes >200 who received zidovudine during pregnancy and delivery and whose infants received zidovudine for the first 6 weeks of life [22] . nancy and at delivery, 70% were positive. Twenty-four percent of infants born to women who were always culture-positive during pregnancy were infected, compared with 19% of infants born to women who were sometimes positive and only 7% of infants born to women who were never culture-positive during pregnancy (P = .001, Mantel extension test) (table 3) . Thus, infants of women who always had a positive culture had more than three times the likelihood of being infected than did those whose mothers never had a positive culture. Restricting the analysis to women with~2 cultures and using the last 2 cultures showed similarly significant trends (data not shown). Neither site nor method ofculture significantly affected this association (data not shown). Furthermore, while there were minor differences in the frequency of positive cultures at each visit, there were no significant trends over time, nor was there a difference in percentage of positive cultures for women with (table 3) . Again, these findings were similar but not significant in the 106 women who were receiving zidovudine during pregnancy.
After October 1991, quantitative PBMC cultures for HIV replaced qualitative ones. Mean IUPM titers at the four pregnancy visits were similar to each other, and a repeated-measures analysis failed to detect any significant change in IUPM during the course ofpregnancy. Geometric mean virus load titers were calculated for each woman across all available pregnancy visits (table 3) . Thirty-one percent of infants born to mothers with mean IUPM titers of~40.5 were infected, compared with 17% of infants born to mothers with titers between 0.72 and 40.5 IUPM and 14% of infants born to mothers with <0.72 IUPM (P = .012). In this analysis, infants whose mothers had mean virus titers of~40.5 IUPM during pregnancy were more than twice as likely to be infected as those whose mothers' values were below that level. Here, too, the relationships of IUPM and infant infection were similar among those receiving and not receiving zidovudine but were statistically significant only in the larger group of those not receiving zidovudine (P = .045).
Interrelationship ofmaternal immunologic and virologic status and infant infection. To determine the relative contributions of maternal immunologic and virologic status, these were considered together as variables in table 4. In this analysis, the cohort of women with available data for both immunologic and virologic status were divided into eight categories representing the four lymphocyte quartiles and the dichotomized variable, always and not always HIV culture-positive. The three categories of culture status were collapsed to two to analyze the findings in approximately equal-size groups.
A significant trend was observed in the relationship between mother-to-infant transmission and percentages of CD4 and CDS cells and CDS cell subsets CDS/CD3S, CDS/CD57, and CDS/DR among women whose HIV cultures were not always positive but not among women whose cultures were always positive. Moreover, women in the highest CD4 cell percentage quartile who were not always culture-positive had the lowest risk of having an infected infant. When an odds ratio was 24 calculated by a logistic regression model based on these data, women who were always culture-positive and were in the lowest quartile of CD4 cell percentage had infected infants with a frequency 12 times that seen in women with any negative culture and CD4 cell percentages in the highest quartile. The relationships between positive cultures and high versus low CD8 cell percentage and transmission were similar. When the infants with indeterminate infectious status were included in the analysis as either all infected or all uninfected, the CD4 cell-viremia interaction term remained significant (P = .017, P = .002, respectively.)
The CD8 cell subsets, CD8/DR, CD8/CD38, and CD8/ CD57, were all significantly associated with maternal HIV transmission when examined in the context of viral status. Again, it was among women who were not always HIV culture-positive that CD8 cell activation seemed to playa role (P < .001, P < .001, and P = .001, respectively). All of these relationships remained significant among those not receiving zidovudine and were similar but not significant among those receiving zidovudine. When controlled for culture status, percentages of CD3, CD16/56, and CD19 cells were not significantly associated with transmission in this cohort (data not shown).
In a logistic regression on maternal CD8 cell percentage, viremia status, viremia-CD8 cell interaction, and each (separately) of the CD8 cell activation/differentiation markers and its viremia interaction term, the activation/differentiation markers and their viremia interaction term remained in the model, while CD8 cell data and its viremia interaction term were excluded. This suggests that at least in the population after October 1991, CD8/DR, CD8/CD57, and CD8/CD38 cell data, controlled for maternal viremic status, each had a stronger association with transmission than did CD8 cell data similarly controlled for maternal viremic status.
Multivariate model. Multivariate logistic regression was used to examine which immunologic and virologic variables were significant, after controlling for other relevant covariables. The immunologic and virologic variables included CD4 cell percentage, CD8 cell percentage, culture positivity, and the interaction of culture positivity with CD4 and CD8 cell percentage. The covariates included zidovudine use, birth weight <2.5 kg, gestational age <37 weeks, maternal drug use, and duration of ruptured membranes <4 h versus 4-24 h versus >24 h. Zidovudine was included, although it was not significant in univariate analysis. The other covariates were statistically significant by univariate analysis (data not shown), and some have been the subject of other reports from this cohort [23] . For 112 women, at least one of the measurements in the multivariate analysis was missing and these subjects were therefore excluded. Of these, 54 were missing infant birth weight and 31 were missing duration of ruptured membranes. The excluded women did not differ from the included ones in transmission rate, viremia status, or CD4 cell percentage quartile but had a marginally significant shift toward the higher quartiles of CD8 cell percentage (P = .04). The transmission rate in each CD4 and CD8 cell percentage quartile was similar in the included and excluded group (data not shown). model, CD4 and CD8 cell percentages, culture positivity, the interaction of culture positivity and CD8 cell percentage, duration of ruptured membranes, and maternal drug use all remained significant while prenatal zidovudine, gestational age, and birth weight were excluded from the final model by backward elimination.
Discussion
Recent studies among HIV-infected adults have observed the interaction between virus load and CD4 cell count [24] [25] [26] . In this report, we have demonstrated that viral culture status, CD4 and CD8 cell subsets, and CD8 cell data-viral culture status interaction were all independently associated with transmission of HIV to the infant. In addition, percentages of CD8 cell subsets, CD8/CD38, CD8/CD57, and CD8IDR, were associated with transmission after controlling for viral culture status and appeared to better describe the women predisposed to transmission than did CD8 cell percentage. In all cases examined, lymphocyte phenotype data appeared to have no significant relationship to infant infection in those who were always culture-positive but a profound one in those who were not always culture-positive.
Women in the highest CD4 cell percentage quartile or the lowest CD8 cell percentage quartile had a 0-4% risk for infant HIV transmission. This was in contrast to transmission risks in the 17%-25% range among women in all CD4 and CD8 cell percentage quartiles whose cultures were always positive. There was little alteration in these coefficients when they were placed in a model including other significant variables such as maternal drug use, duration of ruptured membranes, prenatal zidovudine, gestational age, and birthweight.
Although there is a significant relationship between CD4 and CD8 cell percentages (they are often considered reciprocal since they are, under most conditions, the components of total CD3 cell percentage [27] ), there was an independent association of both CD4 and CD8 cell percentages with maternal HIV transmission; both remained in the multivariate model. Moreover, even though CD4 or CD8 cell percentages (or both) were associated with being never, sometimes, or always positive, these variables had independent as well as interactive associations with infant outcome.
One may speculate on the biologic significance of the interaction of immunologic factors with PBMC HIV cultures. Perhaps immune containment of HIV in tissue and secretions may further affect local concentrations of HIV and the inoculum of exposure to the infant only in cases in which the immune system is not overwhelmed with virus. It may also be possible that virus status has its greatest effect in women whose lymphocyte phenotypes diverge least from the normal, the most normal one or two quartiles of lymphocyte phenotype measurements. These findings support the hypothesis that any possible effect on virus status, such as reduction of virus load or reduction of growth rate or infectivity of the virus, could further improve the good prognosis for infants of women with high CD4 cell percentages.
Several previous perinatal cohort studies have shown that the risk of maternal transmission of infection was increased in patients with symptomatic HIV infection or lower CD4 lymphocyte counts [4] [5] [6] , although not all investigators have agreed with the latter finding [1, 2] . The data in this study refine this observation by demonstrating that maternal CD4 cell data were not associated with transmission under conditions of persistent culture positivity but strongly associated under conditions in which cultures were not always positive.
The results also demonstrated the importance of CD8 and activated CD8 cell markers in transmission and their similar interaction with positive culture status. St. Louis et al. [5] had previously noted a relationship between increased CD8 lymphocytes and perinatal HIV-1 transmission, but their observations were limited to absolute CD8 cell counts, and they saw a significant relationship only when CD8 cell counts were > 1800/mm 3 • That this relationship was seen in that study and ours but not in others may have been due to the fact that both studies used the CD3 marker in defining CD8 lymphocytes. Furthermore, our results revealed the association of CD8 cells and transmission as a linear trend of higher transmission risk across ascending CD8 cell percentage quartiles, a trend that was entirely due to the contribution of mothers whose cultures were not always positive.
There is an extensive literature describing the anti-HIV effects of CD8 T lymphocytes [28] [29] [30] . Recent studies have associated soluble factors produced by CD8 cells with anti-HIV activity. Perhaps in women with high CD8 cell percentages and not always positive cultures, these soluble factors are reducing infectious virus in the blood, which is what is sampled, but are not present or active in the compartment( s) of virus important for maternal-infant transmission. One cannot assume, however, that increased CD8 cell percentage results in increased activity of circulating virus inhibitors. Possibly the CDS cells may proliferate in association with diminished capacity to produce these cytokines. In immune deficiency disorders, there may be a proliferation of a cell phenotype in the presence of the loss of function of that cell or its effector. Alternatively, cytokines associated with CDS cells may be more likely to be present in the setting of not always positive cultures, enhancing tissue damage and thus contributing to the likelihood of maternalinfant transmission.
The activated CDS cells, CDS/CD3S and CDS/DR, were associated more closely with mother-to-infant transmission than were CDS cells alone. These markers have also been noted to be helpful in assessing disease progression in adults with high levels of CDS cells [31] [32] [33] . High levels of CDS+CD3S+DR+ T cells have recently been associated with rapid progression of disease, while nonprogressors have high levels of CDS+CD3S-DR+ cells [34] .
Other studies have demonstrated a relationship of maternal virus load with transmission [4, 7, 35] . In our cohort, 31% of all children from mothers having geometric mean titers of at least 40.5 IUPM were infected. This compared with 16% of infants born to mothers with IUPM titers of 0.72-40 IUPM and 13% of mothers with <0.72 IUPM. Thus, these data suggest that women with mean viral titers in pregnancy of~40.5 have a lower likelihood of transmission than those with higher titers but does not support the idea of a threshold, as has been suggested by Weiser et al. [7] . More recently Dickover et al. [9] and Fang et al. [S] have documented a significant association of maternal plasma HIV RNA and transmission, as have recent reports from the WITS cohort, from ACTO 076, from the Ariel project, and from a Centers for Disease Control and Prevention study in Thailand [36] [37] [38] [39] .
The importance of persistently positive qualitative cultures during pregnancy as a determinant of maternal-infant transmission has not previously been examined. We found a significantly lower transmission rate among women who had consistently negative cultures than among those who consistently had positive cultures, with an intermediate rate in those who had both negative and positive cultures. Burke et al. [40] and Mellors et al. [41] both have used the frequency of detectable p24 antigen, culture, and RNA in subjects as indicators of virus load and predictors of clinical outcome. While it seems plausible that the likelihood of a positive qualitative culture is related to the inoculum, we have not ruled out the possibility that these results may also reflect differences among viral phenotypes, infectivity, and growth rate.
In this study, the interaction of maternal viral culture status and immunologic status as measured by lymphocyte phenotypes was surprising and surprisingly consistent. The stepwise increase in proportion of infected infants with mothers belonging to sequential quartiles of CD4, CDS, CDS/3S, CDS/CD57, and CDSIDR cell percentages was driven by the findings in women who did not always have positive cultures. In addition, the CDS cell activation/differentiation markers appeared to be more predictive of transmission than did CDS cell levels alone. CDS cell subsets were not included in the final model, however, because the first 27% of the cohort did not have this measurement made.
These findings, with vertical transmission as an end point, differ in several ways from studies of lymphocyte phenotypes and viral status as predictors of disease progression in several ways. This pregnant population is healthier, with higher CD4 lymphocyte levels and fewer positive viral cultures. For example, only 7% of pregnant women in this study had CD4 cell counts <200. There was, therefore, no reason to assume that cutoffs found informative for predicting the development of opportunistic infection would be useful in predicting motherto-infant transmission. In addition, lymphocyte subset counts were not found to give as sharp discrimination as percentages. For example, women grouped by mean CD4 cell count quartiles ranged in transmission rates from 17% to 2S% compared with 7% to 30% when CD4 cell percentage quartiles were used. Finally, CDS cell percentage was an independent predictor of transmission, which has not been found in the context of progression.
There were certain limitations to the data presented. The definition of culture positivity, not always versus always positive cultures during pregnancy, is probably a crude proxy for virus load. It may, however, measure characteristics of the infection other than virus load as measured by HIV RNA. Another limitation was that viral status was determined by a single available culture in 100 of the 466 women in whom cultures were available. However, neither the distribution of positive and negative cultures in these women nor the frequency of transmission differed from those in women with more frequent samples. There was, however, a marginally significantly higher frequency of positive cultures at the time of delivery than at the third visit. This was not only true in the aggregate but also in paired samples from the same individual, suggesting a possible biologic mechanism but not ruling out a small sampling bias in addition.
In contrast, the strengths of the study include the large and multisite WITS cohort, which reflects the perinatal HIV epidemic in the United States and therefore allows for generalization of the findings. Another strength is the extensive immunologic and virologic data available with multiple time points in pregnancy and the extensive laboratory and clinical database of the WITS cohort available for analysis. This has allowed for evaluation of the interrelationship of culture positivity with maternal CD4, CDS, and CDS subset percentages as well as the ability to control for other key covariates in multivariate analysis.
In our study, we saw no overall effect of oral maternal zidovudine on reduction of risk of transmission. This may be because at the time of the study few women were receiving zidovudine. Those who were given zidovudine were often given it for their own health and were therefore more advanced clinically. Moreover, few of these women received intravenous zidovudine during labor and almost none of their infants received zidovudine after birth. Infant prematurity and birth weight, highly significant in univariate analysis, also did not remain in the multivariate model.
In summary, in these analyses from a large US perinatal cohort, we have demonstrated that maternal culture positivity during pregnancy and maternal CD4 and CD8 percentages, as well as CD8 subset percentages, each contribute to the risk of HIV transmission to the infant. Moreover, viral status has its greatest effect in the women with lymphocyte phenotypes closer to normal, and lymphocyte phenotypes had most of their effect in women with at least 1 negative culture. It thus appeared that in the presence of lower viral infectivity, as measured by viral culture, the integrity of the maternal immune system played a very important role in determining the likelihood of transmission. It is likely that in the presence of relative integrity of the immune system, reduction of viral infectivity can reduce the likelihood of transmission.
